A1LN34 (Brazil) Market Value

A1LN34 Stock  BRL 73.50  0.84  1.16%   
A1LN34's market value is the price at which a share of A1LN34 trades on a public exchange. It measures the collective expectations of A1LN34 investors about its performance. A1LN34 is trading at 73.50 as of the 23rd of December 2024, a 1.16% up since the beginning of the trading day. The stock's open price was 72.66.
With this module, you can estimate the performance of a buy and hold strategy of A1LN34 and determine expected loss or profit from investing in A1LN34 over a given investment horizon. Check out A1LN34 Correlation, A1LN34 Volatility and A1LN34 Alpha and Beta module to complement your research on A1LN34.
Symbol

Please note, there is a significant difference between A1LN34's value and its price as these two are different measures arrived at by different means. Investors typically determine if A1LN34 is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, A1LN34's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

A1LN34 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to A1LN34's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of A1LN34.
0.00
11/23/2024
No Change 0.00  0.0 
In 30 days
12/23/2024
0.00
If you would invest  0.00  in A1LN34 on November 23, 2024 and sell it all today you would earn a total of 0.00 from holding A1LN34 or generate 0.0% return on investment in A1LN34 over 30 days. A1LN34 is related to or competes with Novo Nordisk, Vertex Pharmaceuticals, Moderna, BIONTECH, BeiGene, Bio Techne, and Ascendis Pharma. Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA ... More

A1LN34 Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure A1LN34's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess A1LN34 upside and downside potential and time the market with a certain degree of confidence.

A1LN34 Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for A1LN34's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as A1LN34's standard deviation. In reality, there are many statistical measures that can use A1LN34 historical prices to predict the future A1LN34's volatility.
Hype
Prediction
LowEstimatedHigh
70.7573.5076.25
Details
Intrinsic
Valuation
LowRealHigh
59.8662.6180.85
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as A1LN34. Your research has to be compared to or analyzed against A1LN34's peers to derive any actionable benefits. When done correctly, A1LN34's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in A1LN34.

A1LN34 Backtested Returns

At this point, A1LN34 is very steady. A1LN34 secures Sharpe Ratio (or Efficiency) of 0.0101, which signifies that the company had a 0.0101% return per unit of return volatility over the last 3 months. We have found twenty-eight technical indicators for A1LN34, which you can use to evaluate the volatility of the entity. Please confirm A1LN34's Mean Deviation of 1.73, coefficient of variation of 30211.46, and Downside Deviation of 3.37 to double-check if the risk estimate we provide is consistent with the expected return of 0.0279%. The firm shows a Beta (market volatility) of 0.19, which signifies not very significant fluctuations relative to the market. As returns on the market increase, A1LN34's returns are expected to increase less than the market. However, during the bear market, the loss of holding A1LN34 is expected to be smaller as well. A1LN34 today shows a risk of 2.75%. Please confirm A1LN34 coefficient of variation, jensen alpha, sortino ratio, as well as the relationship between the information ratio and total risk alpha , to decide if A1LN34 will be following its price patterns.

Auto-correlation

    
  -0.74  

Almost perfect reverse predictability

A1LN34 has almost perfect reverse predictability. Overlapping area represents the amount of predictability between A1LN34 time series from 23rd of November 2024 to 8th of December 2024 and 8th of December 2024 to 23rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of A1LN34 price movement. The serial correlation of -0.74 indicates that around 74.0% of current A1LN34 price fluctuation can be explain by its past prices.
Correlation Coefficient-0.74
Spearman Rank Test-0.68
Residual Average0.0
Price Variance1.73

A1LN34 lagged returns against current returns

Autocorrelation, which is A1LN34 stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting A1LN34's stock expected returns. We can calculate the autocorrelation of A1LN34 returns to help us make a trade decision. For example, suppose you find that A1LN34 has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

A1LN34 regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If A1LN34 stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if A1LN34 stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in A1LN34 stock over time.
   Current vs Lagged Prices   
       Timeline  

A1LN34 Lagged Returns

When evaluating A1LN34's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of A1LN34 stock have on its future price. A1LN34 autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, A1LN34 autocorrelation shows the relationship between A1LN34 stock current value and its past values and can show if there is a momentum factor associated with investing in A1LN34.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in A1LN34 Stock

A1LN34 financial ratios help investors to determine whether A1LN34 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in A1LN34 with respect to the benefits of owning A1LN34 security.